
Dynavax Investor Relations Material
Latest events

Q4 2024
Dynavax
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Dynavax Technologies Corporation
Access all reports
Dynavax Technologies Corporation is a biopharmaceutical company that develops and commercializes novel vaccines and immunotherapies. The company focuses on leveraging its proprietary Toll-like Receptor (TLR) immune modulation technology to enhance the efficacy of its products. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Key slides for Dynavax Technologies Corporation


Q1 2024
Dynavax Technologies Corporation


Q3 2024
Dynavax Technologies Corporation
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
DVAX
Country
🇺🇸 United States